| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | -9.62% | +0.54% | -10.16% | -10.16% | — |
| 14d | 1 | +100.00% | +0.40% | +0.36% | +0.04% | +0.04% | — |
| 30d | 1 | +0.00% | -16.53% | +0.45% | -16.98% | -16.98% | — |
| 60d | 1 | +100.00% | +5.12% | +1.56% | +3.56% | +3.56% | — |
| 90d | 1 | +100.00% | +9.64% | -0.24% | +9.88% | +9.88% | — |
| 180d | 1 | +100.00% | +15.70% | -2.97% | +18.67% | +18.67% | — |
| 1y | 1 | +100.00% | +182.65% | +13.88% | +168.76% | +168.76% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 900,000 | — | — | 900,000 | Mar 5, 2026 | Mar 6, 2026 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel and Secretary | 6,075 | — | — | 0 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE General Counsel and Secretary | 6,075 | — | — | 33,565 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel and Secretary | 2,502 | $1.80 | $4.5K | 31,063 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,735 | — | — | 27,555 | Dec 19, 2025 | Dec 19, 2025 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel and Secretary | 65 | $1.68 | $109 | 27,490 | Dec 19, 2025 | Dec 19, 2025 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 750,000 | — | — | 750,000 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel | 6,076 | — | — | 6,075 | Feb 11, 2025 | Feb 12, 2025 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE General Counsel | 6,076 | — | — | 28,260 | Feb 11, 2025 | Feb 12, 2025 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel | 2,440 | $0.65 | $1.6K | 25,820 | Feb 11, 2025 | Feb 12, 2025 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE General Counsel | 15,000 | $0.60 | $9.0K | 22,184 | Nov 26, 2024 | Nov 26, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 650,000 | — | — | 650,000 | Mar 7, 2024 | Mar 8, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel/Secretary | 2,490 | $1.08 | $2.7K | 7,184 | Feb 11, 2024 | Feb 12, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE General Counsel/Secretary | 6,076 | — | — | 9,674 | Feb 11, 2024 | Feb 12, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel/Secretary | 6,076 | — | — | 12,151 | Feb 11, 2024 | Feb 12, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 650,000 | — | — | 650,000 | Mar 9, 2023 | Mar 10, 2023 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel/Secretary | 6,076 | — | — | 18,227 | Feb 11, 2023 | Feb 14, 2023 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE General Counsel/Secretary | 6,076 | — | — | 6,076 | Feb 11, 2023 | Feb 14, 2023 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE General Counsel/Secretary | 2,478 | $1.35 | $3.3K | 3,598 | Feb 11, 2023 | Feb 14, 2023 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 650,000 | — | — | 650,000 | Mar 10, 2022 | Mar 11, 2022 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 24,303 | — | — | 24,303 | Feb 11, 2022 | Feb 15, 2022 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 695,000 | — | — | 695,000 | Sep 1, 2021 | Sep 2, 2021 ↗ | View → |